These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17577900)

  • 1. Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state.
    Guilloreau L; Combalbert S; Sournia-Saquet A; Mazarguil H; Faller P
    Chembiochem; 2007 Jul; 8(11):1317-25. PubMed ID: 17577900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper transfer from Cu-Abeta to human serum albumin inhibits aggregation, radical production and reduces Abeta toxicity.
    Perrone L; Mothes E; Vignes M; Mockel A; Figueroa C; Miquel MC; Maddelein ML; Faller P
    Chembiochem; 2010 Jan; 11(1):110-8. PubMed ID: 19937895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical.
    Dikalov SI; Vitek MP; Mason RP
    Free Radic Biol Med; 2004 Feb; 36(3):340-7. PubMed ID: 15036353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
    Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
    Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron.
    Nakamura M; Shishido N; Nunomura A; Smith MA; Perry G; Hayashi Y; Nakayama K; Hayashi T
    Biochemistry; 2007 Nov; 46(44):12737-43. PubMed ID: 17929832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry.
    Haeffner F; Smith DG; Barnham KJ; Bush AI
    J Inorg Biochem; 2005 Dec; 99(12):2403-22. PubMed ID: 16271394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease.
    Hureau C; Faller P
    Biochimie; 2009 Oct; 91(10):1212-7. PubMed ID: 19332103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer.
    Faller P
    Chembiochem; 2009 Dec; 10(18):2837-45. PubMed ID: 19877000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes.
    Maiti NC; Jiang D; Wain AJ; Patel S; Dinh KL; Zhou F
    J Phys Chem B; 2008 Jul; 112(28):8406-11. PubMed ID: 18570397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties.
    Hureau C; Eury H; Guillot R; Bijani C; Sayen S; Solari PL; Guillon E; Faller P; Dorlet P
    Chemistry; 2011 Aug; 17(36):10151-60. PubMed ID: 21780203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site.
    Karr JW; Kaupp LJ; Szalai VA
    J Am Chem Soc; 2004 Oct; 126(41):13534-8. PubMed ID: 15479110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
    La Penna G; Hureau C; Andreussi O; Faller P
    J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors.
    Talmard C; Bouzan A; Faller P
    Biochemistry; 2007 Nov; 46(47):13658-66. PubMed ID: 17983245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.
    Karr JW; Szalai VA
    Biochemistry; 2008 Apr; 47(17):5006-16. PubMed ID: 18393444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble amyloid beta1-28-copper(I)/copper(II)/Iron(II) complexes are potent antioxidants in cell-free systems.
    Baruch-Suchodolsky R; Fischer B
    Biochemistry; 2008 Jul; 47(30):7796-806. PubMed ID: 18598056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amylin peptide implicated in type 2 diabetes stimulates copper-mediated carbonyl group and ascorbate radical formation.
    Masad A; Tabner BJ; Mayes J; Allsop D
    Free Radic Biol Med; 2011 Aug; 51(4):869-75. PubMed ID: 21683137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms.
    Drew SC; Masters CL; Barnham KJ
    J Am Chem Soc; 2009 Jul; 131(25):8760-1. PubMed ID: 19496610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
    Jun S; Gillespie JR; Shin BK; Saxena S
    Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.